From the Editor-in-Chief
"Of all the forms of inequality, injustice in health is the most shocking and inhuman.”
–Dr. Martin Luther King Jr.
by William G. Nelson, MD, PhD
The Evolution of Cancer | Breast Density Matters | More Options for Adolescents in Clinical Trials | Choosing a Cancer Center | The Cost of Prescriptions | Tackling Drug Resistance | Scientists Take a Stand | By The Numbers
Your Cancer Guide
Follow these tips for discussing your diagnosis and treatment plan with your kids.
by Hester Hill Schnipper
Caregiving With Confidence
Develop a system to avoid being overwhelmed by health care bills and information.
by Aimee Swartz
More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.
by Sue Rochman
A self-taught musician takes what he has learned from his experience with kidney cancer to entertain, teach and inspire.
by Jenny Song
Before undergoing surgery, cancer patients should look for experienced surgeons, get second opinions and ask about the risks and benefits.
by Stephen Ornes
Physicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.
by Kate Yandell
Inflammation Connection | Small Strides
Researcher Tom Marsilje is helping fellow colorectal cancer patients sort through clinical trials.
Assisting a co-worker with cancer, what you should ask your doctor, and dating and cancer.
Ann W. Calahan started Joe's House to help cancer patients and others find places to stay when they're being treated away from home.
by Cameron Walker
Karyn Marshall, James Gathright, Catherine Hargrove.
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer.
by Judy Pearson
The AACR led a contingent of 130 organizations in asking that cancer patients and survivors be granted high priority in receiving COVID-19 vaccinations.
Eliminating disparities requires consistent effort on numerous fronts, including the development and sustenance of a diverse scientific workforce.
In March of last year, screenings for breast, colon and cervical cancer decreased by roughly 90% compared with historical rates.
Learning Medicare’s ABCDs
donate to the AACR